Psychological Harms Among Male Performance-Enhancing Drug Users, 2024 Survey

Survey data from 785 males reporting past-year image and performance-enhancing drug (IPED) consumption, collected via the 2024 Global Drug Survey. The dataset was analyzed by Etienne Grobler to examine associations between modifiable factors and psychological effects. It was last updated in May 2026.

Use Cases

• Modeling the association between dosing regimens (e.g., blast and cruise) and psychological outcomes like irritability.
• Analyzing the relationship between polypharmacy load (e.g., using two IPEDs) and odds of depression.
• Investigating the role of non-modifiable factors like age in psychological risk among IPED users.
• Informing targeted harm reduction interventions based on modifiable factors like prescription status and dosage patterns.

Strengths

• Dataset contains 785 survey records, providing a specific sample size.
• Analysis includes specific statistical results, such as an odds ratio of 3.69 for irritability associated with blast and cruise dosing.
• Data is from a recognized international source, the 2024 Global Drug Survey.
• Released under a permissive CC-BY-4.0 license.

Limitations

• Row count for the underlying data is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data may reflect self-reporting and selection bias inherent to voluntary online surveys.

Provenance

Source

2024 Global Drug Survey

Collection Method

Online survey data analyzed by the author.

Time Range

2024

Freshness

Last updated 2026-05-23 12:20:04; freshness should be verified.

Geography

Global